Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer

ConclusionsIt was shown that increasing age was not associated with BCG immunotherapy oncological outcomes, or with BCG toxicity in T1HG non-muscle invasive bladder cancer.

Source: World Journal of Urology - February 17, 2020 Category: Urology & Nephrology Source Type: research